202 related articles for article (PubMed ID: 37304971)
1. Extracellular Vesicles Derived circSH3PXD2A Inhibits Chemoresistance of Small Cell Lung Cancer by miR-375-3p/YAP1.
Chao F; Zhang Y; Lv L; Wei Y; Dou X; Chang N; Yi Q; Li M
Int J Nanomedicine; 2023; 18():2989-3006. PubMed ID: 37304971
[TBL] [Abstract][Full Text] [Related]
2. Hsa_circ_0041150 serves as a novel biomarker for monitoring chemotherapy resistance in small cell lung cancer patients treated with a first-line chemotherapy regimen.
Zhang Y; Chao F; Lv L; Li M; Shen Z
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15365-15382. PubMed ID: 37639013
[TBL] [Abstract][Full Text] [Related]
3. CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p/IGF1R/AKT axis.
Hua J; Wang X; Ma L; Li J; Cao G; Zhang S; Lin W
Mol Cancer; 2022 Jun; 21(1):123. PubMed ID: 35668527
[TBL] [Abstract][Full Text] [Related]
4. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis.
Zhong Y; Lin H; Li Q; Liu C; Shen J
Cancer Biomark; 2021; 30(2):261-273. PubMed ID: 33682697
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA cESRP1 sensitises small cell lung cancer cells to chemotherapy by sponging miR-93-5p to inhibit TGF-β signalling.
Huang W; Yang Y; Wu J; Niu Y; Yao Y; Zhang J; Huang X; Liang S; Chen R; Chen S; Guo L
Cell Death Differ; 2020 May; 27(5):1709-1727. PubMed ID: 31728016
[TBL] [Abstract][Full Text] [Related]
6. microRNA-301b-3p from mesenchymal stem cells-derived extracellular vesicles inhibits TXNIP to promote multidrug resistance of gastric cancer cells.
Zhu T; Hu Z; Wang Z; Ding H; Li R; Wang J; Wang G
Cell Biol Toxicol; 2023 Oct; 39(5):1923-1937. PubMed ID: 35246762
[TBL] [Abstract][Full Text] [Related]
7. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis.
Chu D; Li P; Li Y; Shi J; Huang S; Jiao P
Thorac Cancer; 2021 Nov; 12(21):2894-2906. PubMed ID: 34523261
[TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis.
Chang N; Ge N; Zhao Y; Yang L; Qin W; Cui Y
J Clin Lab Anal; 2022 May; 36(5):e24304. PubMed ID: 35312115
[TBL] [Abstract][Full Text] [Related]
9. Blocking circ-SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR-338-3p and regulating LIN28B.
Qiu F; Qiao B; Zhang N; Fang Z; Feng L; Zhang S; Qiu W
Cancer Cell Int; 2021 Aug; 21(1):412. PubMed ID: 34353342
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
11. TSPAN12 promotes chemoresistance and proliferation of SCLC under the regulation of miR-495.
Ye M; Wei T; Wang Q; Sun Y; Tang R; Guo L; Zhu W
Biochem Biophys Res Commun; 2017 Apr; 486(2):349-356. PubMed ID: 28302484
[TBL] [Abstract][Full Text] [Related]
12. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
13. Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A.
Pan B; Chen Y; Song H; Xu Y; Wang R; Chen L
Oncotarget; 2015 Jan; 6(1):317-31. PubMed ID: 25426560
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
[TBL] [Abstract][Full Text] [Related]
15. The malignant property of circHIPK2 for angiogenesis and chemoresistance in non-small cell lung cancer.
Ren M; Song X; Niu J; Tang G; Sun Z; Li Y; Kong F
Exp Cell Res; 2022 Oct; 419(2):113276. PubMed ID: 35863454
[TBL] [Abstract][Full Text] [Related]
16. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
Xie H; Yao J; Wang Y; Ni B
Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
[TBL] [Abstract][Full Text] [Related]
17. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).
Zhu X; Han J; Lan H; Lin Q; Wang Y; Sun X
BMC Cancer; 2020 Dec; 20(1):1190. PubMed ID: 33276753
[TBL] [Abstract][Full Text] [Related]
18. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).
Wei D; Zeng J; Rong F; Xu Y; Wei R; Zou C
Bioengineered; 2022 Mar; 13(3):5126-5140. PubMed ID: 35170372
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miR-92b-3p Promotes Chemoresistance of Small Cell Lung Cancer Through the PTEN/AKT Pathway.
Li M; Shan W; Hua Y; Chao F; Cui Y; Lv L; Dou X; Bian X; Zou J; Li H; Lin W
Front Cell Dev Biol; 2021; 9():661602. PubMed ID: 34136482
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
[No Abstract] [Full Text] [Related]
[Next] [New Search]
